¹Ý·Áµ¿¹° °üÀý¿° ½ÃÀå : ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м®°ú ¿¹Ãø(2024-2032³â)
Companion Animal Arthritis Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
»óǰÄÚµå : 1572398
¸®¼­Ä¡»ç : Global Market Insights Inc.
¹ßÇàÀÏ : 2024³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 196 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,850 £Ü 7,017,000
PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,050 £Ü 8,753,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,350 £Ü 12,081,000
PDF & Excel (Enterprise User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ¹Ý·Áµ¿¹° °üÀý¿° ½ÃÀåÀº 2023³â¿¡´Â ¾à 34¾ï ´Þ·¯·Î Æò°¡µÇ¸ç, 2024-2032³â CAGRÀº 7.2%·Î ¼ºÀåÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¹Ý·Áµ¿¹° »çÀ° ¼ö Áõ°¡°¡ ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Áõ°¡´Â ÀǾàǰ ¹× º¸ÃæÁ¦¸¦ Æ÷ÇÔÇÑ ¹Ý·Áµ¿¹° °Ç°­°ü¸® Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹ ¹Ý·Áµ¿¹°¿ëǰÇùȸ(American Pet Products Association)ÀÇ Àü±¹ ¹Ý·Áµ¿¹° ¼ÒÀ¯ÀÚ Á¶»ç(National Pet Owners Survey)¿¡ µû¸£¸é ¾à 8,690¸¸ °¡±¸(66%)ÀÇ ¹Ì±¹ °¡Á¤ÀÌ »õ¿Í °í¾çÀÌ¿¡¼­ °³¿Í Èò Á·Á¦ºñ±îÁö ´Ù¾çÇÑ ¹Ý·Áµ¿¹°À» Ű¿ì°í ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ±â¸£°í ÀÖ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ¶ÇÇÑ Àü ¼¼°è¿¡¼­ ¹Ý·Áµ¿¹° »çÀ°ÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ÷´Ü Áø´Ü Åø¿Í ´õ °­·ÂÇÑ Ä¡·á ¿É¼Ç°ú °°Àº ¼öÀÇÇÐ ºÐ¾ßÀÇ ±â¼ú ¹ßÀüÀÌ °áÇÕµÇ¾î ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº Ä¡·á È¿°ú¸¦ ³ôÀ̰í Ä¡·áÇÒ ¼ö ÀÖ´Â Áõ»óÀÇ ¹üÀ§¸¦ È®´ëÇÕ´Ï´Ù.

µ¿¹°º´¿ø¿¡¼­´Â ¹Ý·Áµ¿¹°ÀÇ °üÀý ¹®Á¦¸¦ Áø´ÜÇϱâ À§ÇØ MRI(ÀÚ±â°ø¸í¿µ»ó), CT(ÄÄÇ»ÅÍ´ÜÃþÃÔ¿µ)¿Í °°Àº ÷´Ü ¿µ»óÁø´Ü ±â¼úÀ» Ȱ¿ëÇÏ´Â °æ¿ì°¡ ´Ã°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÅøÀº ¼öÀǻ翡°Ô °üÀý ±¸Á¶¸¦ º¸´Ù ¼±¸íÇÏ°Ô º¸¿©ÁÜÀ¸·Î½á º¸´Ù Á¤È®ÇÑ Ä¡·á °èȹÀ» ¼¼¿ï ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ¶ÇÇÑ ·¹ÀÌÀú Ä¡·á, ¸ÂÃãÇü ÀçȰ ÇÁ·Î±×·¥, Ȱµ¿·® ÃøÁ¤±â µî Çõ½ÅÀûÀÎ Ä¡·á ±â¼ú°ú Àåºñ°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

Ä¡·á À¯Çü¿¡ µû¶ó ¾à¼öó¸®, º¸ÃæÁ¦, ¼ö¼ú, ±âŸ Ä¡·á·Î ±¸ºÐµÇ¸ç, 2023³â¿¡´Â ¾à¼öó¸® ºÐ¾ß°¡ 15¾ï ´Þ·¯¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¹Ý·Áµ¿¹°ÀÇ °üÀý¿° Áõ»óÀ» ¿ÏÈ­Çϱâ À§ÇØ ¼öÀÇ»ç´Â ÀϹÝÀûÀ¸·Î NSAIDs, ÄÚ¸£Æ¼ÄÚ½ºÅ×·ÎÀ̵å, Áúº´ º¯Çü °ñ°üÀý¿° Ä¡·áÁ¦(DMOADs)¿Í °°Àº ÀǾàǰÀ» ó¹æÇÏ¿© ÅëÁõ ¿ÏÈ­ ¹× ¿°Áõ °¨¼Ò¿¡ ÁßÁ¡À» µÓ´Ï´Ù. Çâ»óµÈ Áø´Ü ¹æ¹ýºÎÅÍ °­·ÂÇÑ ¾à¹° ¹× Àü¹ÝÀûÀÎ Ä¡·á ÇÁ·ÎÅäÄÝ¿¡ À̸£±â±îÁö ¼öÀÇÇÐÀÇ ¹ßÀüÀº °üÀý¿° Ä¡·áÀÇ È¿°ú¿Í Á¢±Ù¼ºÀ» Çâ»ó½ÃÄ×½À´Ï´Ù.

¹Ý·Áµ¿¹° °üÀý¿° ½ÃÀåÀº °ñ°üÀý¿°, ·ù¸¶Æ¼½º °üÀý¿°, ±âŸ ÁúȯÀ¸·Î ºÐ·ùµÇ¸ç, 2023³â¿¡´Â °ñ°üÀý¿°ÀÌ 64.3%ÀÇ ¾ÐµµÀûÀÎ Á¡À¯À²·Î ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °ñ°üÀý¿°Àº ¹Ý·Áµ¿¹°¿¡°Ô ÈçÇÑ ÁúȯÀ¸·Î, ³ë·É °³¿Í °í¾çÀÌÀÇ 20%°¡ ¾Î°í ÀÖÀ¸¸ç, °üÀý ¿¬°ñÀÇ ÅðÇà°ú ±×¿¡ µû¸¥ »ÀÀÇ º¯È­¸¦ À¯¹ßÇÕ´Ï´Ù. ±Û·çÄÚ»ç¹Î, Äܵå·ÎÀÌÆ¾, ¿À¸Þ°¡ 3 Áö¹æ»ê°ú °°Àº °Ç°­ º¸Á¶ ½Äǰ°ú °°Àº ÀÚ¿¬ÀûÀ̰í ÀüüÀûÀÎ Ä¡·á¹ý¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼­ ¹Ý·Á°ß °ñ°üÀý¿° Ä¡·á Á¦Ç°¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ¿© ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

ºÏ¹Ì´Â 2023³â ¹Ý·Áµ¿¹° °üÀý¿° ¼¼°è ½ÃÀå¿¡¼­ 45.6%ÀÇ ¾ÐµµÀûÀÎ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÇâÈÄ¿¡µµ °ß°íÇÑ ¼ºÀå¼¼¸¦ À̾ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù. ºÏ¹Ì ½ÃÀå È®´ëÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î´Â ¹Ý·Áµ¿¹° »çÀ°ÀÇ ±ÞÁõ, µ¿¹° °Ç°­¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, ¼öÀÇÇÐÀû Ä¡·áÀÇ ¹ßÀü µîÀÌ ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹° °ü¸® ȯ°æÀÌ ÁøÈ­ÇÔ¿¡ µû¶ó ºÏ¹ÌÀÇ ÀÌÇØ°ü°èÀÚ, ƯÈ÷ Çõ½ÅÀûÀÌ°í µ¶Æ¯ÇÑ ½ÃÀå ¼ö¿ä¿¡ ´ëÀÀÇÏ´Â ¾÷üµéÀº Å« ÀÌÀÍÀ» ¾òÀ» ¼ö ÀÖ´Â Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú Á¶»ç ¹üÀ§

Á¦2Àå °³¿ä

Á¦3Àå ¾÷°è ÀλçÀÌÆ®

Á¦4Àå °æÀï ±¸µµ

Á¦5Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Ä¡·á À¯Çüº°, 2021-2032³â

Á¦6Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Áúȯ À¯Çüº°, 2021-2032³â

Á¦7Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : µ¿¹° À¯Çüº°, 2021-2032³â

Á¦8Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : ¿ëµµº°, 2021-2032³â

Á¦9Àå ½ÃÀå Ã߻ꡤ¿¹Ãø : Áö¿ªº°, 2021-2032³â

Á¦10Àå ±â¾÷ °³¿ä

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Global Companion Animal Arthritis Market, valued at approximately USD 3.4 billion in 2023, is set to grow at a CAGR of 7.2% from 2024 to 2032. Increasing pet ownership is a primary driver for the market's growth. This rise has spurred demand for healthcare products for companion animals, including medications and supplements. The National Pet Owners Survey by the American Pet Products Association reveals that around 86.9 million American families, or 66%, own pets, spanning from birds and cats to dogs and ferrets. Moreover, the global uptick in pet adoption, coupled with technological strides in veterinary medicine-like advanced diagnostic tools and more potent treatment options-fuels market growth. These advancements boost treatment efficacy and expand the range of treatable conditions.

Veterinary clinics are increasingly utilizing advanced imaging techniques, such as MRI (magnetic resonance imaging) and CT (computed tomography) scans, to diagnose joint issues in pets. These tools offer veterinarians a clearer view of joint structures, allowing for more precise treatment plans. Furthermore, the market is driven by innovative therapeutic technologies and devices, including laser treatments, tailored rehabilitation programs, and activity monitors.

The overall companion animal arthritis industry is segmented based on treatment type, disease type, animal type, end-use, and region.

The market is segmented by treatment type into medication, food supplements, surgery, and other treatments. In 2023, the medication segment is projected to account for USD 1.5 billion. To alleviate arthritis symptoms in companion animals, veterinarians commonly prescribe pharmaceutical drugs like NSAIDs, corticosteroids, and disease-modifying osteoarthritis drugs (DMOADs), emphasizing pain relief and inflammation reduction. Advancements in veterinary medicine-ranging from enhanced diagnostics to robust medications and holistic treatment protocols-have improved the effectiveness and accessibility of arthritis treatments.

Segmented by disease type, the companion animal arthritis market includes osteoarthritis, rheumatoid arthritis, and other forms. In 2023, osteoarthritis led the market with a commanding 64.3% share. Osteoarthritis, prevalent in pets, impacts nearly 20% of older dogs and cats, leading to joint cartilage degeneration and subsequent bone changes. The rising consumer inclination towards natural and holistic remedies-like nutraceuticals such as glucosamine, chondroitin, and omega-3 fatty acids-signals an uptick in demand for products addressing osteoarthritis in dogs, thus propelling market growth.

North America held a dominant 45.6% share of the global companion animal arthritis market in 2023, with forecasts suggesting continued robust growth. Key drivers for North America's market expansion include surging pet ownership, increased awareness of animal health, and advancements in veterinary care. As the pet care landscape evolves, North American stakeholders-especially those innovating and addressing unique market needs-are poised for significant gains.

Table of Contents

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Industry Insights

Chapter 4 Competitive Landscape, 2023

Chapter 5 Market Estimates and Forecast, By Treatment Type, 2021 - 2032 ($ Mn)

Chapter 6 Market Estimates and Forecast, By Disease Type, 2021 - 2032 ($ Mn)

Chapter 7 Market Estimates and Forecast, By Animal Type, 2021 - 2032 ($ Mn)

Chapter 8 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

Chapter 10 Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â